✦ LIBER ✦

Optimization of symptomatic therapy in Parkinson's disease

✍ Scribed by Hacisalihzade, S.S.; Mansour, M.; Albani, C.

Book ID: 114529661
Publisher: IEEE
Year: 1989
Tongue: English
Weight: 1012 KB
Volume: 36
Category: Article
ISSN: 0018-9294
DOI: 10.1109/10.19857

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current Status of Symptomatic Medical Th

Current Status of Symptomatic Medical Therapy in Parkinson’s Disease

✍ Stewart A. Factor 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 153 KB

Symptomatic medical therapies for Parkinson's disease (PD) have been disease modifying and have led to improvement in daily function, quality of life, and survival. For 40 years, these therapies have been primarily dopaminergic, and currently include the dopamine (DA) precursor levodopa (LD), DA ago

Initiation of symptomatic therapy in Par

Initiation of symptomatic therapy in Parkinson's disease: dopamine agonists versus levodopa

✍ Nirit Lev; Ruth Djaldetti; Eldad Melamed 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 296 KB

Neuroimaging for optimization of stem ce

Neuroimaging for optimization of stem cell therapy in Parkinson's disease

✍ Hayashi, Takuya; Onoe, Hirotaka 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 476 KB

Transdermal therapy in Parkinson's disea

Transdermal therapy in Parkinson's disease

✍ Amos D Korczyn 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 44 KB

Vasopressin therapy in Parkinson's disea

Vasopressin therapy in Parkinson's disease

✍ John P. A. Jensen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Gene therapy in Parkinson’s disease

✍ O. Eberhardt; J. B. Schulz 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 274 KB